Quantcast

Latest Routes of administration Stories

2011-03-01 07:30:00

FRANKLIN, Mass., March 1, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced that it won the prestigious 2011 North American Frost & Sullivan Technology Innovation Award in Pharmaceuticals and Biotechnology. Echo received this award in recognition of...

2010-11-22 05:58:00

JERUSALEM, November 22, 2010 /PRNewswire-FirstCall/ -- Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that that the company's board of directors has approved the research and development of two new medical locking device products. In addition to the company's patented syringe locking device, the company will now seek to develop bar-coded locking devices...

2010-09-21 06:45:00

SOUTHAMPTON, Mass., Sept. 21 /PRNewswire/ -- Product innovators Chris and Sonia Hillios are pleased to announce that they have been granted a patent by the U.S. Patent and Trademark Office pertaining to their new syringe injection system, ConfiDisc(R). The patent covers the innovator's syringe injection system, which enables users to achieve the correct angle and depth of subcutaneous and intramuscular injections. The ConfiDisc(R) Syringe Injection System was developed for insulin and like...

2010-05-21 12:07:00

FRANKLIN, Mass., May 21 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that the Chairman of its Scientific Advisory Board, Dr. Robert Langer, a world-renowned engineer at Massachusetts Institute of Technology (MIT) discussed his...

2010-05-03 08:54:00

PISCATAWAY, N.J., May 3 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application, titled "Self-Administration Injection System." Milestone's innovative computer-controlled drug delivery platform has been designed to reduce the anxiety and pain of self-administration of...

2010-04-02 07:00:00

FRANKLIN, Mass., April 2 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that its Symphony(TM) tCGM System has been featured in a March 31, 2010 online magazine article in Scientific American entitled "This Really Won't Hurt a Bit:...

2009-01-14 16:37:00

SEATTLE, Jan. 14 /PRNewswire/ -- Patients undergoing in vitro fertilization self-administer daily injections of progesterone from two to eight weeks after the egg retrieval procedure. The outcome of a new study of an investigational formulation of progesterone could replace these painful intramuscular injections of progesterone in oil with less painful subcutaneous injections. Seattle Reproductive Medicine (SRM), along with eight other large fertility centers across the country, has...

2008-10-10 09:00:52

Alkermes, a biotechnology company, has announced that patients with schizophrenia now have a new administration option for Risperdal Consta. The FDA has approved a new injection site, the deltoid muscle in the arm, for Risperdal Consta for the treatment of patients with schizophrenia. It was previously approved as a gluteal injection only. The application was based on a study showing that the deltoid and gluteal injections of Risperdal Consta were bioequivalent routes of administration and...

2008-08-05 09:01:31

Vyteris, Inc. (OTC BB: VYTR), manufacturer of the first U.S. Food and Drug Administration (FDA)-approved active patch transdermal drug delivery system, announced an initiative to identify and target candidate drugs in the pain management field that could potentially be delivered using Vyteris' active patch transdermal system. "Our first successful FDA approval for our active patch transdermal system was for topical delivery of lidocaine, and we are now examining other drugs in pain...

7f5e2eb451ecdc59f4119b4fa85d1884
2008-01-08 11:30:00

Painful injections and blood draws may soon be a thing of the past. New polymerization technology may cause the sting of a needle piercing the skin to disappear. For years, biomedical engineers have made attempts to develop a way to deliver drugs intravenously without pain. Until now their closest creation has been a metal microneedle which tends to break upon impact with skin. Roger Narayan and his team of researchers at the University of North Carolina and Laser Zentrum Hanover have...


Latest Routes of administration Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'